Editorial I think of the admonition "be careful what you wish for" when I reflect on the current mix of quality measures in the major pay-for-reporting (P4R) and pay-for-performance (P4P) systems in widespread use. I have considerable personal experience with 2 such systems: (a) the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) and (b) the Centers for Medicare and Medicaid Services (CMS) Physician Quality Reporting System (PQRS). I worked for most of the 1990s managing HEDIS reporting and building a reporting infrastructure for a Blue Cross Plan, and for the past 5 years, I have been managing my institution's collaboration with a leading quality improvement organization to develop, refine, test, and evaluate PQRS measures.
These 2 key quality measurement systems-HEDIS and PQRS-have had beneficial effects on health care quality. Nevertheless, there are clearly opportunities for additional quality improvement, and in fact, the very success of the current highly standardized approach may have produced some unintended consequences. First, given payers' incentives for quality measurement and improvement, health plans, and the hospital and physician providers in their networks, have of necessity focused on these quality measure sets to the exclusion of other quality measures. Given improving but still limited external incentives and limited internal funds, plans and providers have had no feasible alternative.
Nevertheless, these measure sets may not match the demographics and clinical needs of the patient populations of health plans, hospitals, or physician practices. For example, an inner-city patient population with a high proportion of African Americans may have a high prevalence of sickle-cell disease, such that a sickle-cell quality program would be appropriate, yet no major quality measure set includes sickle-cell disease. A similar argument would apply for any condition that is rare for the general population but has a high incidence in a specific locality or subpopulation.
NCQA accreditation of health plans allows for planspecific studies, but only to support improvement of the plan's HEDIS measure performance. At the same time, CMS has made substantial efforts to develop PQRS measures for numerous physician and nonphysician specialties, but the focus has been on conditions with high incidence and high disease burden in the general population.
Thus, I recommend broadening existing systems, and/ or developing new ones, to allow some innovation and customization in quality measure development and utilization. For example, a small but appreciable proportion of total P4R or P4P incentives could be based on use of a measure specific to a plan's or provider's specific patient population. The burden would be on the plan or provider to demonstrate the validity of the measure and the clinical and cost-effectiveness of choosing that measure rather than a nationally standardized measure. The rationale is that, while the plan or provider would bear the incremental cost of using its alternative measure, it most likely would benefit from the better fit between this part of its overall quality measurement and improvement effort and the needs of its members or patients.
An obvious issue is how to minimize overall quality measurement costs and/or identify additional sources of financial support beyond the limited resources of the plans and providers. One option to reduce costs would be to allow selection of quality measures from large existing sets (eg, those of the National Quality Forum [NQF] or the Agency for Healthcare Research and Quality National Quality Measures Clearinghouse). Another option would be expanded foundation support for development of quality measures for specific subpopulations and support for certification or endorsement of new measures. NCQA and NQF already certify or endorse quality measures, but there also is a need for an expanded collection or repository of quality measures that would be both broader in its range of clinical conditions covered and deeper in the applicability of these measures to those specific conditions. NCQA's Patient-Centered Medical Home specifications provide another example of potential customization. The Physician Practice Connections-Patient-Centered Medical Home (PPC-PCMH) Standards encourage use of reminders, care/case management, and quality reviews. To that end, 1 of these 9 standards (No. 2-Patient Tracking and Registry Functions) encourages practices seeking PPC-PCMH certification to have an appropriate disease registry (eg, for patients with diabetes). 1 An extension allowing customization of quality measurement by a health plan or provider would be to require adherence to general technical specifications for disease registries while leaving it to the plan or provider to select the relevant disease(s).
An example of foundation support for refinement of quality measures appears in the Measure Applications Partnership (MAP) convened by the NQF with funding from the Commonwealth Fund. A recommendation of the MAP Clinician Workgroup is to "incorporate 'cascading measures' that can be rolled up for overall reporting and rolled down to target areas in need of improvement." 2 The idea is for clinicians to identify granular processes and indicators that contribute to overall quality improvement and to disaggregate or focus quality measurement and improvement processes accordingly. For example, 2 physician practices might need to measure and improve very different processes to meet the same overarching goals (eg, improving proportions of patients with diabetes who have eye exams or proportions of female patients ages 50-70 who get mammograms).
In summary, let us consider (a) allowing more latitude for health plans and providers to measure and improve quality based on the needs of their specific patient populations and (b) devising mechanisms for payers and other organizations such as foundations to support such customization.
